Pyrexia, commonly known as fever, is a prevalent symptom in various clinical scenarios. It is a complex physiological response to disease, often indicating the presence of infection or inflammation. This article provides a comprehensive guide to understanding and managing pyrexia in clinical practice.
Pyrexia is a result of an altered hypothalamic set point, making the body perceive a normal temperature as suboptimal. This change is usually triggered by pyrogens, substances produced by infectious agents or released by immune cells. The body responds by increasing heat production and reducing heat loss, leading to an elevated body temperature.
Initial assessment should focus on identifying potential sources of infection or inflammation. A detailed history, physical examination, and targeted investigations are crucial. The pattern of fever can provide valuable clues. For instance, intermittent high-grade fever is characteristic of sepsis, while a low-grade fever that worsens in the evening is often seen in tuberculosis.
Management should be directed towards the underlying cause. In infectious causes, appropriate antimicrobial therapy is essential. Fever itself can be managed with antipyretics like paracetamol. However, fever is a physiological response and its suppression should be balanced against the potential benefits it offers in fighting infection.
Close monitoring of patients with pyrexia is crucial. Persistent or recurrent fever despite treatment warrants further investigation. It may indicate an uncontrolled infection, drug fever, or non-infectious causes like malignancies or autoimmune diseases. Follow-up is essential to ensure resolution of the fever and the underlying cause.
Pyrexia is a common yet complex clinical symptom. Understanding its mechanisms, careful assessment, targeted management, and vigilant monitoring are key to effective patient care. As clinicians, we must continually update our knowledge and skills in managing pyrexia to improve patient outcomes.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation